ES2195037T3 - Sistema de prueba elisa para detectar substancias que interfieren con el enlace entre ig e y su receptor. - Google Patents

Sistema de prueba elisa para detectar substancias que interfieren con el enlace entre ig e y su receptor.

Info

Publication number
ES2195037T3
ES2195037T3 ES96944649T ES96944649T ES2195037T3 ES 2195037 T3 ES2195037 T3 ES 2195037T3 ES 96944649 T ES96944649 T ES 96944649T ES 96944649 T ES96944649 T ES 96944649T ES 2195037 T3 ES2195037 T3 ES 2195037T3
Authority
ES
Spain
Prior art keywords
interfer
receiver
link
test system
elisa test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96944649T
Other languages
English (en)
Inventor
Manfred Auer
Franz Hammerschmid
Georg Stingl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2195037T3 publication Critical patent/ES2195037T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

LA INVENCION SE REFIERE A UN ENSAYO PARA UNA SELECCION DE ALTA CAPACIDAD DE LAS SUSTANCIAS QUE INTERFIEREN EN LA FIJACION DE LA IGE HUMANA CON SU RECEPTOR DE ALTA AFINIDAD Y/O DE LAS SUSTANCIAS QUE SON CAPACES DE DESPRENDER DE SU RECEPTOR A LA IGE QUE YA ESTA ENLAZADA, Y PARA EL ANALISIS DIFERENCIAL ENTRE LOS TRASTORNOS AUTOINMUNES Y LAS ALERGIAS CLASICAS.
ES96944649T 1995-12-28 1996-12-23 Sistema de prueba elisa para detectar substancias que interfieren con el enlace entre ig e y su receptor. Expired - Lifetime ES2195037T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9526599.7A GB9526599D0 (en) 1995-12-28 1995-12-28 Elisa test system

Publications (1)

Publication Number Publication Date
ES2195037T3 true ES2195037T3 (es) 2003-12-01

Family

ID=10786124

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96944649T Expired - Lifetime ES2195037T3 (es) 1995-12-28 1996-12-23 Sistema de prueba elisa para detectar substancias que interfieren con el enlace entre ig e y su receptor.

Country Status (12)

Country Link
US (1) US6258549B1 (es)
EP (1) EP0882229B1 (es)
JP (1) JP2000502793A (es)
AT (1) ATE235054T1 (es)
AU (1) AU1305897A (es)
CY (1) CY2470B1 (es)
DE (1) DE69626860T2 (es)
DK (1) DK0882229T3 (es)
ES (1) ES2195037T3 (es)
GB (1) GB9526599D0 (es)
PT (1) PT882229E (es)
WO (1) WO1997024617A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769954B2 (en) * 1996-11-26 2004-02-12 Heska Corporation Method to detect IgE
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US7759133B2 (en) 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
US7604955B2 (en) * 2001-08-13 2009-10-20 Swey-Shen Alex Chen Immunoglobulin E vaccines and methods of use thereof
US20060154372A1 (en) * 2004-12-21 2006-07-13 Arter Thomas C Providing additional motion in assays
US20080206855A1 (en) * 2005-05-06 2008-08-28 Kalypsys, Inc. Automated Compound Screening Using Gel-Permeation Matrix and Pin-Based Sample Transfer
US20110256641A1 (en) * 2010-04-19 2011-10-20 Michael Ling Methods and Systems for Detecting Free IgE
CN110358738B (zh) * 2019-08-22 2021-08-13 中国食品药品检定研究院 一种稳定测定抗IgE抗体药物生物学活性的方法
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US4962035A (en) 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
US5639660A (en) 1988-02-24 1997-06-17 Hoffmann-La Roche Inc. Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE
EP0507586A3 (en) 1991-04-03 1993-03-03 Syntex (U.S.A.) Inc. Immunoassay for immunoglobulins
DK137992D0 (da) * 1992-11-13 1992-11-13 Alk Lab As Fremgangsmaade til paavisning af et immunologisk aktivt stof i en proeve under anvendelse af et maerkningsstof
JPH0772150A (ja) * 1993-09-02 1995-03-17 Tonen Corp ＩｇＥの測定方法
CA2176811C (en) * 1993-12-10 2008-01-29 David Tai Wai Fei Methods for diagnosis of allergy and screening of anti-allergy therapeutics
WO1996001643A1 (en) * 1994-07-08 1996-01-25 Thomas Jefferson University IgE ANTAGONISTS

Also Published As

Publication number Publication date
AU1305897A (en) 1997-07-28
DK0882229T3 (da) 2003-07-14
EP0882229A1 (en) 1998-12-09
JP2000502793A (ja) 2000-03-07
ATE235054T1 (de) 2003-04-15
WO1997024617A1 (en) 1997-07-10
US6258549B1 (en) 2001-07-10
GB9526599D0 (en) 1996-02-28
DE69626860D1 (de) 2003-04-24
EP0882229B1 (en) 2003-03-19
DE69626860T2 (de) 2003-12-04
PT882229E (pt) 2003-07-31
CY2470B1 (en) 2005-06-03

Similar Documents

Publication Publication Date Title
ES2195037T3 (es) Sistema de prueba elisa para detectar substancias que interfieren con el enlace entre ig e y su receptor.
IL120081A0 (en) Assay for evaluating the receptor binding characteristics of amylin agonists and antagonists
ATE366933T1 (de) Assaysystem zur erstbehandlung von darmerkrankungen
DK0941468T3 (da) Et-trins-hybridimmunochromatografisk udstyr og fremgangsmåde til anvendelse heraf
ATE205884T1 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
ES2186796T3 (es) Procedimiento para el tratamiento del asma alergica.
HUP0200400A2 (hu) Fehérjék izolálása és elemzése
AU2805697A (en) Analyte assay using particulate labels
DE69430573D1 (de) Test und reagentien zur identifizierung von antiproliferierenden stoffen
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
PT781145E (pt) Composicoes de diagnostico e sua utilizacao para deteccao de anomalias do sistema nervoso central
WO2002000933A3 (en) Screening assays for identifying modulators of the inflammatory or immune responses
WO2003042659A3 (en) Rapid prion-detection assay
NO972707L (no) Fremgangsmåte ved modulering av LC132 (opioid-liknende) reseptorfunksjon
DE69628847D1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
WO2003008635A8 (en) η-SECRETASE IN VITRO SCREENING ASSAY
DE69921987D1 (de) IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
WO1998049292A3 (fr) Polypeptides associes a des recepteurs activateurs et leurs applications biologiques
PT1222311E (pt) Teste de helicase por electroquimioluminescencia
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DE59608490D1 (de) Reagenz zum Nachweis und zur Isolierung von Kohlehydraten oder Glycanrezeptoren
EP1317564A4 (en) SCREENING METHODS FOR IDENTIFYING G PROTEINS AND OTHER COMPOUNDS THAT MODULATE PHOSPHODIESTERASE (PDE) ACTIVITY
Pacheco-Tovar et al. Associated autoimmunity and lead exposure in childhood